Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 13, 2016 9:30 AM - Nov 15, 2016 5:30 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

13th DIA Japan Annual Meeting 2016

[V7-S1] The Trial Introduction of HTA in Japan - Latest Trends

Session Chair(s)

Shinzo  Hiroi, PhD, MPH, RPh, PMP

Shinzo Hiroi, PhD, MPH, RPh, PMP

Senior Director, Project Management, IDC ICO Real World Solutions

ICON Clinical Research GK, Japan

A Health Technology Assessment (HTA) trial was introduced in Japan in April 2016 and full-scale introduction of cost-effectiveness assessment based on HTA is scheduled in the future. We now must establish common awareness of “the value of pharmaceuticals and medical equipment and the assessment method” among relevant stakeholders. Highly transparent discussion is required from a more comprehensive perspective regarding the ideal cost-effectiveness assessment for balancing the advancement of highly innovative medical technology and the need to sustain currently strained health care financing in Japan. In this session, stakeholders from industry, government, and academia will freely discuss their viewpoint on the latest trends in cost-effectiveness assessment.

Speaker(s)

Kaoru  Manabe, MD, PhD

Trial Introduction of Cost-Effectiveness Evaluations in Japan

Kaoru Manabe, MD, PhD

Ministry of Health, Labour and Welfare (MHLW), Japan

Minister's Secretariat, Senior Deputy Director

Ataru  Igarashi, PhD

From Academia's Perspective (Tentative)

Ataru Igarashi, PhD

The University of Tokyo, Japan

Associate Professor

Makoto  Kobayashi, PhD

From Consulting Firm's Perspective

Makoto Kobayashi, PhD

CRECON Medical Assessment Inc., Japan

Director and Chief Operating Officer

Shuichi  Yamaguchi

Trial Introduction of HTA from Pharmaceutical Industry's Perspective

Shuichi Yamaguchi

Chugai Pharmaceutical Co., Ltd., Japan

Group Manager, External Affairs Department

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.